Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine kinase inhibitors
Authors: Benedetta Stefanini et al
Date: 22 Nov 2023
Scope of interest: hepatological
06 99 39
Recup number
You may also be interested in:
Experience of Frosinone Simt in the management of patients treated with Daratumumab
Authors: D’Amico C. et al.
Date: 2019
Scope of interest: Transfusion Medicine
Read details
Residual C-peptide secretion and endothelial function in type 2 diabetic patients
Authors: Manzella D, Spider E, Abbatecola AM, Grella R, Paolisso G
Date: 2003
Scope of interest: physiopathological mechanisms
Read details
High prevalence of poor quality drug prescribing in older individuals: a nationwide report from the Italian Medicines Agency (AIFA)
Authors: Onder G, Bonassi S, Abbatecola AM, Folino-Gallo P, Lapi F, Marchionni N, Pani L, Pecorelli S, Sancarlo D, Scuteri A, Trifirò G, Vitale C, Zuccaro SM, Bernabei R, Fini M; Geriatrics Working Group of the Italian Medicines Agency
Date: 2014
Scope of interest: ageing
Read details
What to do to
Click on the icon of the service you are looking for and go to the dedicated section. If the service is not in the selection, go to Service Guide
